# FULVESTRANT

NDC: 70771-1626
Generic name: fulvestrant
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20211214

FDA application: ANDA215234

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1626"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1626
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=151b948a-3106-497a-b1c7-479307faeb89